MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$501,313K
Short-term investments
$322,092K
Accounts receivable, net
$127,022K
Inventory
$42,646K
Prepaid expenses and
other current assets
$16,026K
Prepaid taxes
$10,642K
Total current assets
$1,019,741K
Long-term investments
$193,485K
Property and equipment,
net
$153,582K
Deferred tax asset, net of
valuation allowance
$22,824K
Right-of-use assets
$7,035K
Other non-current
assets
$300K
Total assets
$1,396,967K
Total liabilities and
stockholders equity
$1,396,967K
Total stockholders
equity
$1,276,729K
Total liabilities
$120,238K
Accumulated other
comprehensive (loss) gain
-$1,623K
Additional paid-in capital
$1,198,257K
Retained earnings
$80,095K
Total current
liabilities
$107,802K
Lease liability
$7,312K
Other long-term
liabilities
$5,124K
Accrued rebates
$70,717K
Accrued expenses and
other current...
$31,196K
Accounts payable
$4,089K
Current portion of lease
liability
$1,800K
Back
Back
Balance Sheet
source: myfinsight.com
Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. (KRYS)